Dasabuvir, ombitasvir, paritaprevir, and ritonavir and Ustekinumab Subcutaneous
Determining the interaction of Dasabuvir, ombitasvir, paritaprevir, and ritonavir and Ustekinumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets, and Dasabuvir
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dasabuvir, ombitasvir, paritaprevir, and ritonavir-Ustekinumab Subcutaneous Injection
- Dasabuvir, ombitasvir, paritaprevir, and ritonavir-Ustell
- Dasabuvir, ombitasvir, paritaprevir, and ritonavir-UTA
- Dasabuvir, ombitasvir, paritaprevir, and ritonavir-UTA Capsules
- Dasabuvir, ombitasvir, paritaprevir, and ritonavir-UTAC tablets
- Dasabuvir, ombitasvir, paritaprevir, and ritonavir-UTI Relief
- Ustekinumab Subcutaneous-Dasatinib
- Ustekinumab Subcutaneous-Dasetta 1/35
- Ustekinumab Subcutaneous-Dasetta 7/7/7
- Ustekinumab Subcutaneous-DaTscan
- Ustekinumab Subcutaneous-Daunorubicin
- Ustekinumab Subcutaneous-Daunorubicin (Conventional)